These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 8809271)
1. Monitoring drug use in an IPA-model HMO. Cohen P; Jay GT Am J Health Syst Pharm; 1996 Jul; 53(13):1534-6. PubMed ID: 8809271 [No Abstract] [Full Text] [Related]
2. Contractual arrangements between HMOs and medical groups to manage drug costs. Curtiss FR J Manag Care Pharm; 2003; 9(6):572-3. PubMed ID: 14664667 [No Abstract] [Full Text] [Related]
3. HMOs have stake in quelling anger at drug store counters. Manag Care; 2002 Apr; 11(4):26A-26E. PubMed ID: 11980223 [No Abstract] [Full Text] [Related]
4. The pills that ate your profits. Meyer H Hosp Health Netw; 1998 Feb; 72(3):18-22. PubMed ID: 9483145 [TBL] [Abstract][Full Text] [Related]
5. Using evidence for utilization management: an HMO manager's perspective. Schoenbaum SC Ann N Y Acad Sci; 1993 Dec; 703():272-4. PubMed ID: 8192306 [No Abstract] [Full Text] [Related]
6. The Continuous Health Improvement Program: research in an HMO delivery system. Sidorov J HMO Pract; 1997 Jun; 11(2):97-9. PubMed ID: 10168116 [No Abstract] [Full Text] [Related]
7. Use this report card to profile physicians on pharmacy use. Clin Resour Manag; 2001 Jul; 2(7):104-7. PubMed ID: 11482247 [TBL] [Abstract][Full Text] [Related]
8. Managed care in the Northern California Kaiser Permanente health care system. Russo MA Urology; 1998 May; 51(5A Suppl):36-40. PubMed ID: 9610556 [TBL] [Abstract][Full Text] [Related]
9. HMO's selective pharmacy agreements trim spiraling costs but irk independents. Kenkel PJ Mod Healthc; 1990 Nov; 20(47):40. PubMed ID: 10107700 [TBL] [Abstract][Full Text] [Related]
10. Perspectives. Options vs. limits: drug cost strategies reconsidered. Cunningham R Faulkner Grays Med Health; 1997 Sep; 51(38):suppl 4. PubMed ID: 10173171 [No Abstract] [Full Text] [Related]
11. The effect of education and drug samples on antihistamine prescribing costs in an HMO. Schectman JM; Schroth WS; Elinsky EG; Ott JE HMO Pract; 1996 Sep; 10(3):119-22. PubMed ID: 10160286 [TBL] [Abstract][Full Text] [Related]
12. Managed care and medical technology: implications for cost growth. Chernew M; Fendrick AM; Hirth RA Health Aff (Millwood); 1997; 16(2):196-206. PubMed ID: 9086669 [TBL] [Abstract][Full Text] [Related]
13. Health maintenance organizations, independent practice associations, and cesarean section rates. Tussing AD; Wojtowycz MA Health Serv Res; 1994 Apr; 29(1):75-93. PubMed ID: 8163381 [TBL] [Abstract][Full Text] [Related]
14. Changing clinical practice: messages, messengers, and methods. Stuart ME HMO Pract; 1996 Sep; 10(3):100-2. PubMed ID: 10160283 [No Abstract] [Full Text] [Related]
16. Managing prescription drug costs in medical groups. Rubinstein E; Saikami D; Nee C Med Group Manage J; 1992; 39(3):62, 64, 72-3. PubMed ID: 10119003 [No Abstract] [Full Text] [Related]
17. The case for hospitalists: effectiveness or expediency? Rivo ML J Am Board Fam Pract; 1997; 10(5):379-81. PubMed ID: 9297666 [No Abstract] [Full Text] [Related]
18. After physicians protest, an HMO changes its mind. Bilodeau A Manag Care; 1996 Jul; 5(7):44-7. PubMed ID: 10159321 [No Abstract] [Full Text] [Related]
19. Financial risk relationships and adoption of management strategies in physician groups for self-administered injectable drugs. Agnew JD; Stebbins MR; Hickman DE; Lipton HL J Manag Care Pharm; 2003; 9(6):523-33. PubMed ID: 14664660 [TBL] [Abstract][Full Text] [Related]